Jacobs Levy Equity Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $828K | Buy |
194,450
+119,531
| +160% | +$509K | ﹤0.01% | 791 |
|
|
2025
Q1 | $282K | Hold |
74,919
| – | – | ﹤0.01% | 988 |
|
|
2024
Q4 | $437K | Hold |
74,919
| – | – | ﹤0.01% | 830 |
|
|
2024
Q3 | $895K | Sell |
74,919
-12,478
| -14% | -$149K | ﹤0.01% | 743 |
|
|
2024
Q2 | $946K | Buy |
87,397
+12,478
| +17% | +$135K | ﹤0.01% | 756 |
|
|
2024
Q1 | $848K | Sell |
74,919
-74,740
| -50% | -$846K | ﹤0.01% | 746 |
|
|
2023
Q4 | $2.1M | Sell |
149,659
-94,813
| -39% | -$1.33M | 0.01% | 594 |
|
|
2023
Q3 | $3.02M | Buy |
244,472
+169,553
| +226% | +$2.09M | 0.02% | 481 |
|
|
2023
Q2 | $677K | Sell |
74,919
-155,649
| -68% | -$1.41M | ﹤0.01% | 764 |
|
|
2023
Q1 | $800K | Buy |
230,568
+178,740
| +345% | +$620K | ﹤0.01% | 742 |
|
|
2022
Q4 | $127K | Sell |
51,828
-28,091
| -35% | -$68.8K | ﹤0.01% | 923 |
|
|
2022
Q3 | $221K | Buy |
+79,919
| New | +$221K | ﹤0.01% | 924 |
|